Jointherapeutics

Join Therapeutics is a biotechnology company focused on developing innovative therapies for joint diseases, specifically targeting osteoarthritis and chronic joint pain. The company utilizes its proprietary JOIN platform, which leverages advanced biomaterials and hydrogel-based drug delivery systems to provide sustained release of therapeutic agents directly into the joint space. Their lead programs aim to improve patient outcomes by reducing inflammation and promoting tissue repair while minimizing systemic side effects. By combining expertise in polymer chemistry and musculoskeletal biology, Join Therapeutics seeks to transform the standard of care for millions suffering from degenerative joint conditions.